Please assess the completion status of the following clinical trial:

Trial Title: Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Any male age 40 or older~* Scheduled to undergo one of the planned surgeries (thoracic, general, or urologic)~* Ability to give informed consent~Exclusion Criteria:~* Current use of alpha blocker~* Current use of a strong CYP 3A4 inhibitors~* Any allergy to tamsulosin, alpha-blocker medication class, or anaphylaxis allergy to sulfate containing medications~* Patients with any upcoming surgery for cataracts~* Currently enrolled in a clinical trial~* Inability to give informed consent

- Gender: MALE
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Tamsulosin Group (Type: EXPERIMENTAL): Subjects will receive:~1. 0.4mg tamsulosin by mouth nightly for 3 doses prior to the day of surgery and for 2 doses following surgery~2. education about signs and symptoms of urinary retention
- Education Group (Type: ACTIVE_COMPARATOR): Subjects will receive:~1) education about signs and symptoms of urinary retention

Based on this trial design, predict the completion outcome and termination type (if applicable).